Is Genome Safe?

Company size:

Founded in 2018, Genome started out as a simple e-wallet concept that has very quickly grown since its inception, expanding its offering significantly for both personal users and businesses. Today, the electronic money institution offers the ability to send and receive SWIFT and SEPA international transfers, exchange currencies, open merchant accounts and open dedicated multi-currency accounts which are accompanied by virtual and physical cards for both businesses and individuals, powered by VISA, for which Genome is a principal member.

Genome is based in Vilnius, Lithuania and is licensed and supervised by the Bank of Lithuania, legally registered as UAB “Maneuver LT”. Their market proposition is maximum financial instruments for minimum effort, whereby Genome has significantly simplified the on-boarding process of traditional banks, and also makes the transition easier for a user to upgrade from a personal, to business, even through to opening merchant accounts.

Genome currently has more than 60 employees and a leadership team headed by two very experienced professionals in the Fintech Space. Founder Artem Tymoshenko, is a Forbes finance council member who has held Chief Executive positions for the last decade. Current CEO Daumantas Barauskas has a deep knowledge in Fintech with more than 20 years experience. He has been with Genome since its inception, starting out as Head of BD and Sales and has helped to shape Genome into the all-in-one finance ecosystem it is today. Whilst Genome isn’t particularly prevalent in the Fintech News space, in an interview earlier this year, Daumantas outlined the firm’s short term focus. “For now, the team will continue working on establishing more contactless features, which are in high demand in our fast-paced, digital world”. Keeping up with consumer digital trends is a key focus for Genome, as its banking cards are now Apple Pay, Google Pay and even Garmin Pay friendly. Genome has also invested heavily to ensure their business offering can be adopted by as many potential clients as possible, offering integration with a number of high profile e-commerce and CMS platforms including Shopify and Magento.

Genome is also taking the right steps to maximise their brand presence. They produce a frequently updated blog that is rich with detailed how-to guides and a well produced ‘Genome Month in Review’, which translates to an active Linkedin page with more than 1,500 followers. As part of this Genome review, we did however, spot a couple of small but significant errors on their website. The most crucial of which is one of Genome’s links to its privacy policy (which all new customers have to read and agree to) leading to a ‘page unknown 404’ link. It is possible to navigate to the privacy policy from other working links elsewhere on the site but with customer confidence being such a significant barrier to convert traditional bank users into the digital market, it’s important for Genome to strive for prevention rather than correction for such significant errors for the sake of their brand reputation.

Genome offers both personal and business services to residents of 40 countries, mostly within the EEA and UK but also to a select number of countries outside these regions including; Singapore, South Africa, Australia, New Zealand, and Canada. That being said, Genome is only registered as an Electronic Money Institution in Lithuania, with a licence issued by the Bank of Lithuania. As such, we’ve not concluded exactly how Genome is able to onboard non EEA residents as there is no mention of any other licences in any other regions or under alternative regulatory bodies. We strongly suggest all users who are not EU residents take time to understand the service they’re being offered and under what regulatory body. Genome is a client of ECOVIS ProventusLaw law firm, who have been instrumental in approving Fintechs in recent years. Genome has likely been advised to gain their licence in Lithuania due to the process being comparatively quick and cost-effective compared to other EU countries. The decision to issue a licence in Lithuania is taken within 3 months from the date of application, compared to 12 months or more in other European destinations, however Lithuania is not widely regarded for being as credible as other leading EU regulators such as the Netherlands, Germany or Ireland.

Regulated By:

• ✓  Bank of Lithuania – Electronic Money Licence – 304785124 (EU)
  

Awards:

None.

Conclusion:

Genome has continued to evolve and expand its offering since launch, moving forward on its mission to become an all-in-one global financial ecosystem and a leading online money transfer platform. It has a strong leadership team that is driving results, and the number of new features including the introduction of physical cards in the last year, are likely all driving factors for an impressive financial year for Genome, having more than doubled its revenue YoY.

They have a range of fees in place and a fixed percentage markup on exchange rates (as detailed later in this Genome review) which gives us confidence Genome has a sustainable business model that is not in any immediate threat from a spike in customer usage threatening their profits. That said, these fees and markups do mean that there are more established competitors that will likely be able to offer better rates, therefore Genome will need to add value in other areas to continue growing its customer base. They certainly have a European friendly offering that offers a number of attractive benefits to its customers, including acceptance of more than 40 payment methods to fund transfers within Europe and the ability to open up to 15 IBANs in multiple currencies with ease.

Genome makes reference to the fact that customer funds are held in separate ‘safeguarded accounts’. However, we do not necessarily believe this means, in the event Genome were to go insolvent, customer funds would be protected under a deposit scheme. In Lithuania, deposit insurance is governed by the Republic of Lithuania Law on Insurance of Deposits and Liabilities to Investors, which transposes the provisions of the EU Deposit Guarantee Schemes Directive. The Bank of Lithuania guarantees up to €100,000 for money held by individuals in one bank or credit union. The legislation does not directly reference if firms operating with an electronic money licence are eligible under the scheme. For this reason we certainly think it’s worth establishing this with Genome at the onset of opening an account. In the UK, US and Australia, e-money institutions are not included in the relevant deposit schemes. If funds are not covered by the Bank of Lithuania we would be concerned by the use of ‘safeguarded’ terminology.

Genome Reviews by Customers

Research:

As of September 2024, Genome’s review scores show varied reception across different platforms. On TrustPilot, the firm holds a score of 2.7/5, based on 126 reviews. The Apple App Store presents a more favorable view, with a score of 4.6/5 from 408 reviews. Meanwhile, on the Google Play Store, Genome maintains a steady rating of 3.7/5, based on 635 reviews. These figures suggest a mixed user experience, with the majority of positive feedback concentrated on the Apple platform.

Conclusion:

Despite there now being a total of 1,169 Genome reviews across various platforms, the ratings reflect a noticeable inconsistency in customer experiences. The overall average rating of 3.7/5 across all platforms suggests a more balanced user experience, with higher satisfaction on the Apple App Store contrasted by less favorable reviews on TrustPilot. This discrepancy indicates that the variability in user satisfaction might stem from platform-specific factors, rather than a single area of weakness, such as app performance.

The verdict on Genome’s customer service continues to be mixed. While some customers praise the service for its responsiveness and friendliness, others report less positive experiences, particularly regarding issues like account freezes and blocked funds. However, Genome’s 93% response rate to negative reviews on TrustPilot, with an average reply time of under two days, remains impressive. The detailed and customer-specific nature of their replies shows a commitment to addressing concerns, though the frequency of negative feedback still raises concerns about consistency in service quality.

Genome Exchange Rates and Fees

Fees:

For personal users, there are no account opening or ongoing monthly fees for EEA and UK residents. Non-EEA residents are able to open an account without paying an initial fee but will pay 20 Euros a month (or 200 Euros a year) as a monthly account fee. Business fees are divided into two tariffs based on whether your business is considered high risk or low risk. Genome provides a very clear and detailed breakdown of all other fees with a separate, dedicated page for both business and personal users, that includes incoming and outgoing transfers fees for SWIFT and SEPA payments. Whilst this breakdown of fees does exist on the company website, given there is no public calculator on the website, it’s not clear from our research how forthcoming Genome is about these fees at the time of transfer. We would hope that any applicable fees are clearly stated on a preview screen prior to completing a transaction, so that the user does not have to refer back to an extensive list of fees and make calculations themselves for each transaction.

Genome is transparent regarding their currency card service fees and has a comprehensive table of all fees, the key items of which we’ve summarised in the below table:

Bank-to-bank transfers in and out of a Genome account are charged at the following rates:

The only difference in bank transfer fees for individuals in the EEA and non-EEA is with regard to SWIFT fees for outbound transfers. EEA residents are required to pay 15 EUR, whilst non-EEA residents have to pay a higher 25 EUR. The best international money transfer services, as rated by MoneyTransferComparison, offer fee-free outbound transfers, no matter how a payment is made.

One other fee to note is that for both personal and business users, Genome charges an inactivity fee for accounts that have been dormant for 6 months. This is a monthly fee of 10 Euros that will continue to be charged throughout long periods of inactivity, either until the user begins re-using the account or until their balance reaches zero.

Exchange Rates:

Genome offers users a simple proposition, adding a 1% markup on top of their stated current interbank rate across all exchange transactions. The trading currency, as well as the total amount and frequency of user transactions will ultimately decide how competitive this offering is, although it’s likely that if trading with major currencies, established competitors such as Wise would take a smaller margin. Similarly, we would advise those looking to make larger transactions to compare competitive offerings, as the 1% markup for larger transactions could well be beatable by other money transfer companies such as TorFX or Currencies Direct. For those using the Genome debit card to make purchases in a foreign currency, a 2% markup is applied rather than the 1% for bank-to-bank transfers.

It is commonplace for many money transfer companies to have a live calculator on their website, so that you’re able to preview a transfer and receive details on rates and fees prior to downloading an app or registering. Genome does not offer this feature therefore, potential customers who had not yet registered to use the service, would need to calculate the 1% markup plus any other applicable fees themselves, which may be off putting for some. This also means that Genome does not publicly advertise their interbank rate for unregistered users. We would advise that customers who do register to use the service always compare the offered interbank rate either with what is listed on Google or via a currency calculator offered by a reliable competitor such as the aforementioned Wise.

Limits:

For personal users, there are several transfer limit levels that a user can progress through, starting with a €1,000 incoming and €1,000 outgoing transfer limit. In the initial instance, this is a yearly limit, however upon progressing up from the initial tier, the limits then begin to reset monthly. To progress to the next transfer limit, customers have to fill in a short questionnaire and occasionally upload documents for verification. Genome claims this is a very quick process and once the request has been made, it should usually only take a maximum of a few days for them to approve.

There are no more specific details available in regards to the limit of each level, however from screenshots in their help section, it appears Genome’s wallet limits are per 30 day rolling period, although it is not clear whether they have any additional rolling limits (e.g. 6 monthly) and whether these or their annual limits are also tiered. We can also see that outgoing limits can be increased to at least €10,000 per 30 days and incoming limits to at least €5,000 per 30 days.

For those using Genome’s debit card, the following payment and withdrawal limits apply and cannot be increased.

Conclusion:

Since their launch, Genome has greatly expanded its range of services, now offering money transfers, virtual and physical debit cards, and multi-currency digital bank accounts. This puts Genome in direct competition with the likes of major players in the industry like Wise and Revolut. Wise shares a similar pricing structure to Genome with no monthly fees but adds a transparent payment fee onto each transaction, and in virtually all cases they’re cheaper than Genome. This differs from the likes of Sokin and the Revolut premium service, which instead charge monthly fees for unlimited transfers with no payment fees.

Whilst an offering like Sokin’s will no doubt be attractive to many customers, the promise of unlimited fee free transfers and zero ATM fees raised a lot of eyebrows here at Money Transfer Comparison, particularly around the sustainability of this business model. Genome however, seem to have a more sustainable business model based on the various payment fees they have in place. It’s also encouraging that as of 2021, Genome has started to make a net profit (2021 net profit – €230,000), suggesting that their business model is solid and that their offering is starting to gain traction in the market, as revenue increased >100% YoY in 2021.

However with all that said, it is still difficult to ignore that multiple well established competitors will likely be offering a more competitive FX markup than 1%, depending on the transaction size. It’s likely Genome reviews its competitors’ service regularly, and are looking to win and retain business by differentiating in other ways versus engaging in a flat out pricing battle. Other notable fees that stand out are the 10 EUR charge to receive faster payments in the UK (we don’t know of any other fintech provider that charges inbound fees, especially as high as this) and the 15/25 EUR fee for outbound SWIFT transfers. As we’ve already stated, there are plenty of money transfer providers not charging a dime in payment fees, even when sent over the SWIFT network.

Finally, as the account limits are confusing and the maximum sending limits are not made transparent by Genome, it’s not clear if their services will be available to those looking to make significantly larger transfers (in excess of €1 million). Therefore, customers looking to make larger transfers may need to turn to currency brokers that regularly handle larger transfers like Currencies Direct and moneycorp.

Genome Global Presence

Research:

• Dedicated Dealer: No
• Offices: Vilnius, Lithuania
• Ways to approach: Email, live chat (web), phone – no operating hours available
• Translations: Genome dashboard is available in 9 languages
• Accepts clients: 39 countries across UK, EU, Africa, Oceania, Asia
• Currencies Handled: GBP, EUR and USD
• Client reviews: Mixed reviews, approximately 60/40 ratio positive/negative

Conclusion:

Genome’s offering is clearly geared toward UK and EEA businesses and residents, although it’s certainly advantageous for their overall reach that the firm offers its services to a number of countries outside those regions, albeit for an additional monthly cost and higher fees. Non EEA residents looking for a similar service without the monthly fee should consider Wise. Non EEA businesses looking to avoid the higher fees have WorldFirst (business only) as a potential alternative.

Being able to open additional multi currency accounts, for free and seemingly hassle free, will surely be advantageous for customers and businesses who frequently work or exchange between UK, EU and US corridors. The expensive inbound and outbound payment fees are however off putting. Particularly for those who are regularly receiving money via customers or friends in the UK/rest of world.

We’re curious to see whether Genome announces plans to increase the amount of currencies it handles, as competitors such as Wise and Revolut handle a significantly wider range of currencies. Now that Genome has started to become profitable, we may start to see them looking to expand their offering to new currencies and geographies, however, Genome remain fairly quiet and have not made much noise in the fintech news space regarding their future plans so we will have to sit back and wait to see their next move.

As part of this Genome review, we’ve found both positive and negative aspects regarding their level of service. Many customers will benefit from their online portal being available in 9 languages. They also have a regularly updated blog that includes a number of comprehensive guides relating to all facets of their business. However, we were disappointed to find that those trying to reach out to Genome for assistance, will not be able to find their operating hours anywhere on their site. They do include a link on one of their help pages supposedly linking to the operating hours, however, this directs you to their generic contact page where this information is not available.

Conclusion:

Genome’s currency exchange services are designed for individuals and businesses to take the spot rate, therefore they do not offer dedicated dealers, however business users opening a merchant account do have access to a dedicated account manager. There is an array of options for those looking to hedge the currency markets and many of the best money transfer services on the market have been reviewed elsewhere on our site.

As far as Genome’s plans to expand their global reach, there are still a lot of question marks as the company has not gone on record to state any specific details of their future growth plans. CEO Daumantas Barauskas has said “we will also be expanding our transfer services to many more countries. I really feel like we caught the rhythm from the very start and aren’t planning to stop”. By only offering GBP, EUR and USD transfers, this is surely Genome’s biggest product limitation as things stand. And given that Genome a currently only regulated in Lithuania, which has a notoriously easier on-boarding process than other regions, whatever new territories they look to expand to, they’ll have a fairly rigorous regulatory and compliance process to go through, so it will likely be some time before we see Genome announce their entrance to new markets such as the US, unless they’re already working on their development plans in stealth.

The missing contact hours information is certainly worth noting, as it’s the second instance of important missing information on their website that we’ve found during our research for this Genome review. We’d like to see the same level of effort that’s gone into the blog put into the wider website so that key support information is easier for users to find.

Additional Functionalities

Hedging:

None – Spot transfers only

For Business:

Yes – Genome offers quick onboarding for businesses, with a range of business features including; merchant accounts, transfers, currency exchange, dedicated IBAN, and business VISA cards.

App:

Yes – Genome has developed an iOS and Android app, and both business and personal users using a virtual or physical card can link this to Apple Pay and Google Pay. From our research, the vast majority of negative Genome reviews are service related and not associated with the app itself. This is a good indication that the Genome apps are performing consistently, as any persistent issues would normally be highlighted by the app users in reviews.

Genome Payment Card: 

Genome now provides a versatile multi-currency debit card integrated with Visa, compatible with Apple Pay, Google Pay, and Garmin Pay. This card allows users to conduct transactions across different currencies without extra third-party markups, making it a cost-effective option for international payments. Users can also create virtual cards instantly for online payments.

Merchant Services:

One area that very few currency providers have expanded into is merchant acquiring. In this sense, Genome is certainly unique. Providing online sellers with a full scale payment solution – on top of the digital accounts which can receive marketplace revenue, Genome offers online card processing to make sales directly through a website.